Clinical Trial Update: DHPLC Determination of TPMT Polymorphisms.

View source ↗

Summary

Clinical trial update describing a DHPLC method for determining TPMT polymorphisms, potentially informing thiopurine dosing in acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Snippet

Sponsor: National Institute of Cancerología | Conditions: Acute Lymphoblastic Leukemia | Status: UNKNOWN